Juan Miguel Jimenez-Andrade

Juan Miguel Jimenez-Andrade

Auto-generated profile, based on publicly available information

Juan Miguel Jimenez-Andrade

Unidad Académica Multidisciplinaria Reynosa-Aztlán, Universidad Autónoma de Tamaulipas, Reynosa, Tamaulipas, Mexico

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Experimental Neurology
Verified
Journal Article
Closed access
CPChristopher M. Peters
Christopher M. Peters
JJJuan Miguel Jimenez-Andrade
Juan Miguel Jimenez-Andrade
BJBeth M. Jonas
Beth M. Jonas
MSMolly A. Sevcik
Molly A. Sevcik
NKNathan J. Koewler
Nathan J. Koewler
PMPatrick W. Mantyh
Patrick W. Mantyh

10 June 2010 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JJJuan Miguel Jimenez‐Andrade
Juan Miguel Jimenez‐Andrade
WMWilliam G. Mantyh
William G. Mantyh
ABAaron P. Bloom
Aaron P. Bloom
AFAlice S. Ferng
Alice S. Ferng
CGChristopher P. Geffre
Christopher P. Geffre
PMPatrick W. Mantyh
Patrick W. Mantyh

1 April 2016 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
GWGustaf Wigerblad
Gustaf Wigerblad
DBDuygu B Bas
Duygu B Bas
CFCátia Fernades-Cerqueira
Cátia Fernades-Cerqueira
AKAkilan Krishnamurthy
Akilan Krishnamurthy
Kutty Selva NandakumarKutty Selva Nandakumar
Kutty Selva Nandakumar
CSCamilla I. Svensson
Camilla I. Svensson
Objective An interesting and so far unexplained feature of chronic pain in autoimmune disease is the frequent disconnect between pain and inflammation. This is illustrated well in rheumatoid arthritis (RA) where pain in joints (arthralgia) may precede joint inflammation and persist even after successful anti-inflammatory treatment. In the present study, we have addressed the possibility that autoantibodies against citrullinated proteins (ACPA), present in RA, may be directly responsible for the induction of pain, independent of inflammation. Methods Antibodies purified from human patients with RA, healthy donors and murinised monoclonal ACPA were injected into mice. Pain-like behaviour was monitored for up to 28 days, and tissues were analysed for signs of pathology. Mouse osteoclasts were cultured and stimulated with antibodies, and supernatants analysed for release of factors. Mice were treated with CXCR1/2 (interleukin (IL) 8 receptor) antagonist reparixin. Results Mice injected with either human or murinised ACPA developed long-lasting pronounced pain-like behaviour in the absence of inflammation, while non-ACPA IgG from patients with RA or control monoclonal IgG were without pronociceptive effect. This effect was coupled to ACPA-mediated activation of osteoclasts and release of the nociceptive chemokine CXCL1 (analogue to human IL-8). ACPA-induced pain-like behaviour was reversed with reparixin. Conclusions The data suggest that CXCL1/IL-8, released from osteoclasts in an autoantibody-dependent manner, produces pain by activating sensory neurons. The identification of this new pain pathway may open new avenues for pain treatment in RA and also in other painful diseases associated with autoantibody production and/or osteoclast activation.

1 January 2008 in Molecular Pain
Verified
Journal Article
Open access
JJJuan M Jimenez-Andrade
Juan M Jimenez-Andrade
MHMonica B Herrera
Monica B Herrera
JGJoseph R Ghilardi
Joseph R Ghilardi
MVMarina Vardanyan
Marina Vardanyan
OMOhannes K Melemedjian
Ohannes K Melemedjian
PMPatrick W Mantyh
Patrick W Mantyh
Although a variety of industrial chemicals, as well as several chemotherapeutic agents used to treat cancer or HIV, preferentially induce a peripheral sensory neuropathy what remains unclear is why these agents induce a sensory vs. a motor or mixed neuropathy. Previous studies have shown that the endothelial cells that vascularize the dorsal root ganglion (DRG), which houses the primary afferent sensory neurons, are unique in that they have large fenestrations and are permeable to a variety of low and high molecular weight agents. In the present report we used whole-mount preparations, immunohistochemistry, and confocal laser scanning microscopy to show that the cell body-rich area of the L4 mouse DRG has a 7 fold higher density of CD31+ capillaries than cell fiber rich area of the DRG or the distal or proximal aspect of the sciatic nerve. This dense vascularization, coupled with the high permeability of these capillaries, may synergistically contribute, and in part explain, why many potentially neurotoxic agents preferentially accumulate and injure cells within the DRG. Currently, cancer survivors and HIV patients constitute the largest and most rapidly expanding groups that have chemically induced peripheral sensory neuropathy. Understanding the unique aspects of the vascularization of the DRG and closing the endothelial fenestrations of the rich vascular bed of capillaries that vascularize the DRG before intravenous administration of anti-neoplastic or anti-HIV therapies, may offer a mechanism based approach to attenuate these chemically induced peripheral neuropathies in these patients.

1 September 2007 in Brain Research
Verified
Journal Article
Closed access
CPChristopher M. Peters
Christopher M. Peters
JJJuan Miguel Jimenez-Andrade
Juan Miguel Jimenez-Andrade
MKMichael A. Kuskowski
Michael A. Kuskowski
JGJoseph R. Ghilardi
Joseph R. Ghilardi
PMPatrick W. Mantyh
Patrick W. Mantyh

1 March 2011 in Neuroscience
Verified
Journal Article
Closed access
GCG. Castañeda-Corral
G. Castañeda-Corral
JJJ.M. Jimenez-Andrade
J.M. Jimenez-Andrade
ABA.P. Bloom
A.P. Bloom
RTR N Taylor
R N Taylor
WMW.G. Mantyh
W.G. Mantyh
PMP.W. Mantyh
P.W. Mantyh